CD25-Targeted Regulatory T Cell Depletion: Efficacy of Anti-CD25 Antibody Fragments in Near-Infrared Photoimmunotherapy
Medical Supporter — Мэдээллийн мэдэгдэл
Энэ нийтлэл нь олон улсын эмнэлгийн мэдээллийн эмхэтгэл бөгөөд эмнэлгийн зөвлөгөө биш; таны эмчийн оношлогоо, эмчилгээний төлөвлөгөөг орлохгүй. Энд буй мэдээлэл нь Японы томоохон эмнэлгийн байгууллагуудын нээлттэй эх сурвалжаас эмхэтгэсэн бөгөөд аливаа эмчилгээний тохиромж, үр дүн өвчтөн бүрээр өөр тул мэргэшсэн эмч тус бүрчлэн үнэлэх ёстой.
- November 21, 2019
- 1 min read
Regulatory T (Treg) cells represent an immunosuppressive mechanism that enables cancer cells to evade immune surveillance. Depletion of intratumoral Treg cells may lead to tumor regression. However, complete elimination of Treg cells could also damage the immune system. Near-infrared photoimmunotherapy (NIR-PIT) is a treatment modality that causes selective cell death of specific cells within the tumor.
An antibody-photoabsorber (IRDye700DX) conjugate (APC) binds to the tumor and, upon irradiation with near-infrared (NIR) light, causes rapid death of these cancer cells. CD25-targeted NIR-PIT has been shown to induce depletion of Treg cells within the tumor microenvironment.
In this preclinical study, researchers compared the efficacy of the antibody fragment anti-CD25-F(ab')2-IR700 versus the intact antibody anti-CD25-IgG-IR700 in a mouse model. Four groups were evaluated:
- No treatment
- Anti-CD25-IgG-IR700 i.v. only
- Anti-CD25-F(ab')2-IR700 + NIR irradiation
- Anti-CD25-IgG-IR700 i.v. + NIR irradiation
While both CD25-targeted NIR-PIT approaches significantly suppressed tumor growth, anti-CD25-F(ab')2-IR700 demonstrated superior tumor growth inhibition compared to anti-CD25-IgG NIR-PIT. The absence of the Fc protein in the APC accelerated clearance and promoted more effective activation of T cells within the tumor.
Disclaimer: Medical Supporter translates overseas clinical trial data and pharmaceutical information for informational purposes only. Translation materials are for reference only. Please consult your healthcare provider for medical decisions.
Source: https://bibgraph.hpcr.jp/abst/pubmed/31498995
Animal Study | Photoimmunotherapy | CD25 | Treg
- Discovering the key to aggressive pancreatic cancer!
- New immune enhancers boosting cancer immunotherapy
- Kyoto University launches iPS cell cancer treatment!
Medical Supporter was formerly certified as an international medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).
Японд эмчлүүлэхээр төлөвлөж байна уу? Мэдээлэл, тусламж хэрэгтэй юу?
Бид Японд эмчлүүлэхэд шаардлагатай мэдээллийг эмхэтгэх, Японы эмнэлгийн байгууллагуудтай холбогдох, хоёр дахь саналын зөвлөгөө зохион байгуулахад тусална.Анхны зөвлөгөө үнэгүй; зөвлөх таны дараагийн алхмыг тодорхой болгоход тусална.
Figure 1
Figure 2
Figure 3
Figure 4